Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Costa Cruz, Pedro Henrique"'
Autor:
Miyake, Kotaro, Costa Cruz, Pedro Henrique, Nagatomo, Izumi, Kato, Yuki, Motooka, Daisuke, Satoh, Shingo, Adachi, Yuichi, Takeda, Yoshito, Kawahara, Yukio, Kumanogoh, Atsushi
Publikováno v:
In Cell Reports 25 July 2023 42(7)
Autor:
Melike Fusun Demir, Yu-Hsien Lin, Costa Cruz, Pedro Henrique, Masaki Tajima, Tasuku Honjo, Müller, Elisabeth
Publikováno v:
Frontiers in Immunology; 2024, p1-15, 15p
RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain
Autor:
Kim, Jung In, Nakahama, Taisuke, Yamasaki, Ryuichiro, Costa Cruz, Pedro Henrique, Vongpipatana, Tuangtong, Inoue, Maal, Kanou, Nao, Xing, Yanfang, Todo, Hiroyuki, Shibuya, Toshiharu, Kato, Yuki, Kawahara, Yukio
Publikováno v:
PLoS Genetics
Adenosine deaminase acting on RNA 1 (ADAR1), an enzyme responsible for adenosine-to-inosine RNA editing, is composed of two isoforms: nuclear p110 and cytoplasmic p150. Deletion of Adar1 or Adar1 p150 genes in mice results in embryonic lethality with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b057fe7c12c8a7ac0694af9e76d8093c
http://europepmc.org/articles/PMC8118328
http://europepmc.org/articles/PMC8118328
Autor:
Costa Cruz, Pedro Henrique, Kato, Yuki, Nakahama, Taisuke, Shibuya, Toshiharu, Kawahara, Yukio
Publikováno v:
RNA; 2020, Vol. 26 Issue: 4 p454-469, 16p
Autor:
Uemura, Yuri, Oshima, Takuya, Yamamoto, Munetaka, Reyes, Charles Jourdan, Costa Cruz, Pedro Henrique, Shibuya, Toshiharu, Kawahara, Yukio
Publikováno v:
Genes to Cells; Sep2017, Vol. 22 Issue 9, p785-798, 14p
Autor:
Demir MF; Department of Immunology and Genomic Medicine, Kyoto University, Kyoto, Japan.; Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto, Japan., Lin YH; Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto, Japan., Costa Cruz PH; Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto, Japan., Tajima M; Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto, Japan., Honjo T; Department of Immunology and Genomic Medicine, Kyoto University, Kyoto, Japan., Müller E; Department of Immunology and Genomic Medicine, Kyoto University, Kyoto, Japan.; Division of Integrated High-Order Regulatory Systems, Center for Cancer Immunotherapy and Immunobiology, Kyoto, Japan.; Tumor Immunology Group, Institute of Pathology, Oslo University Hospital, Oslo, Norway.; Therapy Prediction In Lung Cancer, Department of Cancer Genetics, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Oct 21; Vol. 15, pp. 1479502. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).
Autor:
Costa Cruz PH; Department of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Osaka, Japan., Kawahara Y; Department of RNA Biology and Neuroscience, Graduate School of Medicine, Osaka University, Osaka, Japan. ykawahara@rna.med.osaka-u.ac.jp.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2181, pp. 309-330.